Hitgen Ltd., of Chengdu, China, is collaborating with Mitsubishi Tanabe Pharma Corp., of Osaka, Japan, to use Hitgen's libraries of DNA-encoded compounds to find small-molecule leads for targets of interest. Hitgen will receive undisclosed technology access and research support payments and is eligible for milestone payments.